InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2023-07-05 00:00:00 ET · period of report 2023-07-01 · accession 0000014272-23-000130 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-07-05 2023-07-01 BMY Weese Michelle EVP, Corp. Affairs M - OptEx $0.00 +1,885 4,135 +84% $0
D 2023-07-05 2023-07-01 BMY Weese Michelle EVP, Corp. Affairs F - Tax $63.95 -682 3,453 -16% -$43.6K
D 2023-07-05 2023-07-01 BMY Weese Michelle EVP, Corp. Affairs M - OptEx $0.00 -1,885 3,770 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2023-07-01 M A 1,885 $0.00 4,135 D — — (F1) The restricted stock units vest in four equal installments beginning on July 1, 2022.
2 Common Common Stock, $0.10 par value 2023-07-01 F D 682 $63.95 3,453 D — — (F2) Shares withheld for payment of taxes upon vesting of restricted stock units.
3 Derivative Restricted Stock Units 2023-07-01 M D 1,885 $0.00 3,770 D — · — to 2025-07-01 1,885 Common Stock, $0.10 par value (F1) The restricted stock units vest in four equal installments beginning on July 1, 2022. (F3) Each restricted stock unit converts into one share of common stock upon vesting.